Inventor · disambiguated record
Sarel Fleishman
Also filed as: FLEISHMAN SAREL · FLEISHMAN SAREL J · FLEISHMAN SAREL-JACOB
9 granted patents·12 pending applications·9 citations·filing 2011–2025
80Inventor score
Files withYEDA RES & DEV13UNIV WASHINGTON CT COMMERCIALI3BAKER DAVID1CALIFORNIA INST OF TECHN1UNIV OXFORD INNOVATION LTD1
Top patents by PatentIndex Score
21 records- 0182US10468119B2Stable proteins and methods for designing sameYEDA RES & DEV·Filed 2016·Granted Nov 5, 2019·3 cites·24 claims
- 0276US9493547B2Binding proteins to the constant region of immunoglobulin GUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2013·Granted Nov 15, 2016·2 cites·17 claims
- 0376US9181300B2Polypeptides for treating and/or limiting influenza infectionUNIV WASHINGTON CT COMMERCIALI·Filed 2014·Granted Nov 10, 2015·1 cites·14 claims
- 0474US12331324B2Versatile peroxidases and uses thereofYEDA RES & DEV·Filed 2024·Granted Jun 17, 2025·0 cites·18 claims
- 0567US10665324B2Method of computational protein designYEDA RES & DEV·Filed 2015·Granted May 26, 2020·2 cites·8 claims
- 0665US9388217B2Polypeptides for treating and/or limiting influenza infectionUNIV WASHINGTON CT COMMERCIALI·Filed 2013·Granted Jul 12, 2016·1 cites·20 claims
- 0758US12427188B2Pyocyanine demethylases and related phenazine degrading agents compositions, methods and systems for interfering with viability of bacteriaCALIFORNIA INST OF TECHN·Filed 2021·Granted Sep 30, 2025·0 cites·24 claims
- 0858US2025122311A1Method for humanizing antibodiesYEDA RES & DEV·Filed 2022·Application pending·0 cites
- 0957US2025092158A1Humanized anti quiescin suefhydrye oxidase 1 (qsox1) antibodies and uses thereofYEDA RES & DEV·Filed 2022·Application pending·0 cites
- 1057US2025327040A1Versatile peroxidases and uses thereofYEDA RES & DEV·Filed 2025·Application pending·0 cites
- 1156US2020058367A1Stable proteins and methods for designing sameYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 1255US8765686B2Polypeptides for treating and/or limiting influenza infectionBAKER DAVID·Filed 2011·Granted Jul 1, 2014·0 cites·9 claims
- 1355US2023201257A1De-novo designed transmembrane polypeptides and their uses in cellular immunotherapyYEDA RES & DEV·Filed 2022·Application pending·0 cites
- 1453US2024043820A1Enzyme variantsUNIV WESTERN AUSTRALIA·Filed 2021·Application pending·0 cites
- 1550US2025297027A1Antibodies to cancer glycosylation and uses thereofYEDA RES & DEV·Filed 2022·Application pending·0 cites
- 1650US2016024155A1Polypeptides for treating and/or limiting influenza infectionUNIV WASHINGTON CT COMMERCIALI·Filed 2015·Application pending·0 cites
- 1749US2023132790A1Variants of beta-glucocerebrosidase for use in treating gaucher diseaseYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 1844US2021292437A1Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of sameYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 1944US2021178207A1Designed, efficient and broad-specificity organophosphate hydrolasesYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 2037US10688330B2Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damageYEDA RES & DEV·Filed 2015·Granted Jun 23, 2020·0 cites·30 claims
- 2132US2019374629A1Thermostable variants of p. falciparum pfrh5 which can be produced in bacterial cellsUNIV OXFORD INNOVATION LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sarel Fleishman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →